Looking ahead to 2024, leaders in digital health anticipate a significant expansion of artificial intelligence (AI) applications in healthcare. Following a notable surge in AI utilisation in 2023, stakeholders are projecting even broader adoption across various healthcare sectors. Key concerns include uncertainties about the future of OpenAI, prompting organisations to reconsider their AI strategies at the enterprise level. Neil Patel from Redesign Health suggests a move toward diversified AI strategies that are less dependent on a single platform, drawing parallels with the concept of a multi-cloud strategy.
Doug Hirsch of GoodRx emphasises the need for the healthcare industry to prioritise the application of technology that addresses fundamental challenges rather than focusing solely on flashy, yet less scalable, solutions. Kourosh Davarpanah, CEO of Inato, observes a swift adoption of AI at all levels of the healthcare industry, especially within traditionally slower-adopting sectors like biopharma. This rapid integration ranges from drug discovery to clinical trial design, signifying a transformative shift in how AI is embraced across the healthcare landscape.
Looking into specific applications, leaders foresee the widespread use of generative AI to solve pressing healthcare issues. This includes transforming claim management, turning unstructured data into actionable insights, and predicting trends to better identify at-risk patients.
The potential for generative AI to address staffing shortages in healthcare is also highlighted, presenting a scalable solution to the projected global shortfall of health workers. Overall, 2024 is envisioned as a pivotal year for the healthcare industry, witnessing a substantial surge in the integration of AI across various domains.
Click here to read the original news story.